Actively Recruiting

Age: 18Years +
FEMALE
Healthy Volunteers
NCT06383858

The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center

Led by The Third Affiliated Hospital of Guangzhou Medical University · Updated on 2024-09-19

50000

Participants Needed

1

Research Sites

282 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Preeclampsia is the main cause of illness and death in pregnant women and fetuses. Currently, there is no effective treatment for preeclampsia in clinical practice, and the fundamental treatment is still termination of pregnancy and placental delivery. Therefore, early prediction of preeclampsia and targeted strengthening of high-risk pregnant women supervision, early intervention and diagnosis and treatment can greatly reduce the serious obstetric complications and perinatal maternal and fetal deaths caused by preeclampsia, which has significant social and clinical significance.

CONDITIONS

Official Title

The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women screened for preeclampsia risk using clinical risk factors listed in NICE guidelines (2019)
  • Pregnant women assessed in the first trimester using maternal factors plus MAP and PLGF with or without UtA-PI, or in the second and third trimesters using PLGF or sFlt-1/PLGF
  • Voluntary participation and signing of informed consent
Not Eligible

You will not qualify if you...

  • Severe fetal malformation or no fetal heartbeat
  • Regular use of aspirin before joining the study
  • Presence of other significant abnormal signs, laboratory test results, or clinical diseases deemed unsuitable by researchers
  • Inability to provide follow-up and delivery information

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

FANG HE

Guangzhou, Guangdong, China, 510150

Actively Recruiting

Loading map...

Research Team

D

Dunjin Chen, Professor

CONTACT

F

Fang He, M.D

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here